Par Drugs and Chemicals (NSE:PAR) Investments And Advances : ₹0 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Par Drugs and Chemicals Investments And Advances?

Par Drugs and Chemicals's Investments And Advances for the quarter that ended in Mar. 2025 was ₹0 Mil.

Par Drugs and Chemicals Investments And Advances Historical Data

The historical data trend for Par Drugs and Chemicals's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Par Drugs and Chemicals Investments And Advances Chart

Par Drugs and Chemicals Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Investments And Advances

Get a 7-Day Free Trial

Par Drugs and Chemicals Quarterly Data
	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Investments And Advances	Get a 7-Day Free Trial															-	-	-	-	-

Par Drugs and Chemicals Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

Par Drugs and Chemicals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Par Drugs and Chemicals Ltd (NSE:PAR) » Definitions » Investments And Advances

Traded in Other Exchanges

N/A

Address

Gotri Vasna Road, 816, Nilamber Triumph, Vadodara, GJ, IND, 390007

Website

https://www.pardrugs.com

Par Drugs and Chemicals Ltd is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for the domestic market as well as for exports to international markets. APIs are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage. The company is dealing in only one segment i.e. manufacturing industry, API.